For the first timehttps://innovationtoronto.com/wp-content/uploads/2019/10/213780_webwe4.jpg, scientists have identified a simple way that can effectively transport medication into the brain – which could lead to improved treatments for neurological and neurodegenerative diseases.
In a study published today in Nature Communications, scientists from Newcastle University, UK, have led an international team in a major breakthrough in unlocking the secrets of how medications can infiltrate the brain.
Blood capillaries in the brain are not permeable to many drugs and the majority are excluded from the brain by a protective barrier, called the blood-brain-barrier (BBB), and current treatment options are risky.
Some viruses, however, have found ways to bypass the BBB and enter the brain. To treat certain neurological and neurodegenerative diseases, medication has to use modified viruses to bypass this barrier and deliver drugs to the area.
The team has now engineered small particles, similar to the size of viruses, from a peptide that can behave like a carrier to the brain and can be packed with drugs for intravenous injection.
Professor Moein Moghimi, who led the research, said: “Crossing the blood-brain-barrier has hindered the industry from effectively addressing central nervous system diseases, including brain tumours, and many neurological diseases like Parkinson’s, Alzheimer’s and Huntington’s.
“This breakthrough – based on more than 10 years of research – has significant implications for crossing BBB and other biological barriers that have created challenges for drug delivery.
“Our breakthrough allows for minimally invasive combination delivery through an intravenous injection of various drugs, peptides and nucleic acid therapeutics to the brain.”
At present, treatment of neurological disorders involves difficulties in ‘packaging’ viruses safely and medication is usually administered by injection into the cerebrospinal fluid, which is not without risks.
The new technological breakthrough in delivering genetic materials to cells in the brain has used a peptide component from a virus that targets the brain (a bacteriophage fd). The peptide was synthesised and modified slightly, and when water was added it spontaneously formed a ‘small, hairy particle’.
Scientists found that when the developed particle was injected into a mouse model, the system targeted the brain, crossing the blood-brain-barrier, reaching neurons and microglia cells in the brain.
Professor Moghimi added: “We are very excited by our research – our delivery system is versatile and amenable to modifications, so, in principle, we can hopefully address shortfalls in drug delivery to the brain through intravenous injection.
“We have a long way to go, but we hope that our technology platform may open up many opportunities to address neurodegenerative diseases with modern therapeutics and genetic drugs.”
Through the mouse model, scientists found their technique was safe. Further research will test the technology in animal disease models in preparation for clinical trials.
Gary Leo, SMDG’s SVP of Corporate Development and former national president and CEO of the ALS Association, USA, said: “Bearing in mind the fact that neurological disorders are growing in incidence faster than any other disease class worldwide, governments will face a huge burden and increasing demands for treatment and support services.
“New knowledge is required to develop effective treatment strategies, and the new technology reported in Nature Communications is a promising achievement to fulfil these goals.”
Learn more: Overcoming the blood-brain-barrier: Delivering therapeutics to the brain
The Latest on: Blood-brain-barrier
[google_news title=”” keyword=”blood-brain-barrier” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Blood-brain-barrier
- Pure Neuro Reviews - Is PureLife Organics PureNeuro Supplement Worth It? Where To Buy, Amazon & Priceon March 22, 2023 at 4:46 pm
Pure Neuro is an excellent brain health supplement developed by PureLife Organics that is designed to assist memory loss, brain fog, and other neurological issues.
- Blood-Brain Barrier Transport Drugs Market Size in 2023-2029: Competitive landscape and Leading Countryon March 19, 2023 at 10:09 pm
A new elaborated report titled as Global Blood-Brain Barrier Transport Drugs Market is now released by industry ...
- Blood–brain barrier articles from across Nature Portfolioon March 19, 2023 at 5:00 pm
The blood–brain barrier acts as a strict control point for what can enter the brain, and is created by tight junctions between endothelial cells lining blood vessels, astroyctic endfeet and a ...
- Researchers develop method to effectively deliver Alzheimer's drugs to brainon March 18, 2023 at 3:29 pm
A group of researchers says an experiment it conducted on mice has demonstrated that Alzheimer's medications can be efficiently delivered to the brain when encapsulated in tiny particles.
- New study finds link between inflammation and long covid symptomson March 14, 2023 at 6:19 am
Three years after long COVID was first documented, the mysteries behind what causes it are starting to be unraveled. Driving the news: Some of the mental symptoms of long COVID like brain fog and ...
- Britain is the fast food capital of Europe – and it’s driving a mental health crisison March 12, 2023 at 10:00 am
Nutrition is a “central yet overlooked and ignored underlying factor in our rising rates of mental illness”, says Kimberley Wilson, a clinical psychologist with a degree in nutrition, in her new book, ...
- Brain Cancer Treatment: How 'Awake Surgery' and Other Innovations are Providing Hopeon March 11, 2023 at 8:52 pm
From "awake surgery" to focused ultrasounds, new research on brain cancer is providing hope for those with the disease ...
- Sugar-coated antibodies cross blood-brain barrier to fight Alzheimer'son March 9, 2023 at 1:41 pm
In the quest to combat Alzheimer's disease, researchers have been hopeful about the use of antibodies to destroy peptides in the brain that cause damaging tangles and plaque buildups. So far though, ...
- Transporting Antibodies Across the Blood–Brain Barrier to Treat Alzheimer’s Diseaseon March 9, 2023 at 1:01 pm
Researchers have developed a new method that uses antibody fragments encapsulated in nanomicelles which can cross the blood-brain barrier and reduce levels of amyloid-beta in the brains of mouse ...
- Novel delivery system transports antibodies across the blood-brain barrier in Alzheimer’s mouse modelon March 9, 2023 at 12:02 pm
One potential explanation for this is that the blood–brain barrier (BBB) prevents most full-length antibodies from entering the brain." Akiko Amano, lead author of the study To address this ...
via Bing News